Transaction DateRecipientSharesTypePriceValue
19th August 2020R Matthew Neff5,000Open or private purchase$4.75$23,750.00
19th August 2020John E Sagartz3,733Open or private purchase$4.75$17,731.75
15th June 2020Robert Jr. Leasure2,884Open or private purchase$5.20$14,996.80
10th June 2020Beth Taylor10,000Grant/award etc.$0.00
21st May 2020Beth Taylor3,300Open or private purchase$4.52$14,916.00
21st May 2020William D Pitchford10,000Open or private purchase$4.47$44,700.00
20th May 2020Beth Taylor4,933Open or private purchase$4.42$21,803.86
19th May 2020Beth Taylor5,067Open or private purchase$4.38$22,193.46
1st April 2020Richard Allen Johnson10,000Grant/award etc.$0.00
1st April 2020R Matthew Neff10,000Grant/award etc.$0.00
Bioanalytical Systems
Bioanalytical Systems logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Bioanalytical Systems, Inc. operates as a pharmaceutical development company. It engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products.


Ticker: BASI
Sector: Health Services
Industry: Services to the Health Industry
SEC Central Index Key (CIK): 720154
Employees: 322
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals